Lexicon Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$61.74M $75.68M $72.80M $50.12M $32.32M $10.70M $4.91M $1.85M $1.09M $2.22M $22.85M $130.01M $79.26M $91.69M $63.21M $322.07M $24.00M $0.30M $0.14M $1.20M $0.00M
GM % Gross Margin %
-46.72% -23.71% -46.56% -105.99% -231.77% 0.00% 0.00% 0.00% 0.00% 0.00% -290.65% 26.79% -106.89% -68.09% -62.53% 70.46% 91.96% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin
-76.86% -47.73% -75.87% -149.56% -298.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.45% -161.34% -140.17% -163.39% 52.81% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$-3.99 $-5.67 $-4.13 $-3.85 $-3.99 $-2.29 $-2.26 $-1.43 $-1.40 $-1.12 $0.05 $-1.37 $-1.23 $-1.14 $1.36 $-1.72 $-0.79 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 -0.00% 0 0 0 0 0 0 -0.00% -0.00% 0.00% -0.00% -0.00% -0.00% 0.00% -0.00% 0 0 -0.00% 0
Sha. Shares
9.06m 9.22m 10.9m 19.54m 19.54m 25.1m 48.22m 48.24m 73.2m 73.36m 103.48m 103.62m 104.04m 105.59m 105.93m 106.27m 107.11m 140.7m 148.9m 244.02m 244.02m
OCF Operating Cash Flow
$-42.26M $23.44M $-56.91M $-74.32M $-95.60M $-89.02M $-82.37M $-87.94M $-94.46M $-91.08M $-75.62M $184.78M $-175.63M $-185.39M $-148.61M $113.81M $-142.97M $-87.02M $-88.85M $-161.90M $0.00M
FCF Free Cash Flow
$-54.07M $12.16M $-60.49M $-76.22M $-97.79M $-89.39M $-83.50M $-89.14M $-94.95M $-92.80M $-75.70M $183.87M $-175.86M $-185.62M $-148.70M $113.74M $-143.06M $-88.24M $-90.18M $-173.18M $0.00M
FCFS Free Cash Flow Per Share
$-5.98 $1.33 $-6.33 $-5.35 $-5.00 $-4.30 $-1.93 $-1.83 $-1.36 $-1.27 $-0.99 $1.77 $-1.69 $-1.76 $-1.41 $1.07 $0.16 $-0.61 $-0.54 $-0.73 $0.00